PharmaShots | Incisive News in 3 Shots

Subscribe Now

Hepatitis B

Ascletis Entered into an Exclusive WW License Agreement with Suzhou Alphamab for ASC22 (envafolimab) to Treat Hepatitis B and Other Viral Diseases

Ascletis Entered into an Exclusive WW License Agreement with Suzhou Alphamab for ASC22 (envafolimab) to Treat Hepatitis B and Othe...

November 8, 2021

Arbutus and Antios Enter into a Clinical Collaboration to Evaluate AB-729 + ATI-2173 for Chronic Hepatitis B Virus Infection

Arbutus and Antios Enter into a Clinical Collaboration to Evaluate AB-729 + ATI-2173 for Chronic Hepatitis B Virus Infection

June 30, 2021

Janssen Collaborates with Arrowhead for the Initiation of REEF-1 P-IIB Study in Patients with Chronic Hepatitis B Infection

Janssen Collaborates with Arrowhead for the Initiation of REEF-1 P-IIB Study in Patients with Chronic Hepatitis B Infection

August 28, 2019

Gilead Signs an Exclusive Worldwide License Agreement with Durect for its HIV and Hepatitis B Products

Gilead Signs an Exclusive Worldwide License Agreement with Durect for its HIV and Hepatitis B Products

July 22, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us